JAMA Publishes Study Results On Efficacy Of The Bard Agento(R) I.C. Silver-Coated Endotracheal Tube In Preventing Ventilator-Associated Pneumonia
C. R. Bard, Inc. (NYSE: BCR) announced the publication of the North American Silver-Coated Endotracheal Tube (NASCENT) clinical study results in the August 20, 2008 edition of the Journal of the American Medical Association (JAMA). The NASCENT study - which enrolled 2,003 patients in 54 hospitals - evaluated the efficacy of the Agento® I.C. silver-coated endotracheal tube (ETT) in the reduction of microbiologically confirmed ventilator-associated pneumonia (VAP). The U.S.
(more...)
(more...)
